Supernus Pharmaceuticals, Inc.
$42.66
▼ 0.63
(-1.46%)
Volume: 607,464
· 2026-09-25
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
45
- 21d momentum -5.0%
- RSI 44
🎯
Pullback
50
- -0.3% vs 20MA
💎
Value
58
- -29% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)43.9
MACD+0.245
MA trendMixed
ATR3.22%
21d mom.-5.0%
63d mom.-8.9%
vs 20MA-0.3%
RVOL(20)0.99×
52w low · 41
52w high · 60
-28.5% from 52-week high
20d support 41
· resistance 45
Computed live from daily OHLCV · as of 2026-09-25
🏦 Fundamentals
Market cap$2.5B
PER—
PBR2.44
PSR3.04
EPS$-1.89
ROE-10.7%
ROA-7.7%
Dividend yield0.00%
Debt/Equity0.00
EV/EBITDA81.99
| week | 1M | 3M | 6M | 1Y | YTD |
|---|---|---|---|---|---|
| +1.57% | -4.95% | -8.92% | -16.02% | -9.43% | -13.77% |
Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.
⚖️ AI Bull vs Bear
14d momentum -2.00%, daily vol 1.49%. Supernus Pharmaceuticals, Inc. sits in a bearish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.